The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Fatigue

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Fatigue.
Olatoyosi Odenike
Connection Strength
0.055
Fatigue
  1. A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. Cancer Chemother Pharmacol. 2004 Dec; 54(6):553-61.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.